{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:48:00Z","timestamp":1761767280558},"reference-count":49,"publisher":"Bentham Science Publishers Ltd.","issue":"12","funder":[{"name":"Beijing Science and Technology Innovation Medical Development Foundation","award":["KC2021-JX-0186-123"],"award-info":[{"award-number":["KC2021-JX-0186-123"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The highly heterogeneous, complex pathological histology, and\nclinical phenotype in bladder cancer (BC) plague the prognostic management of BC to\nthe present day.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>This study was conducted using single-cell sequencing data from the gene expression\nomnibus (GEO) database (GSE135337). A descending, annotated analysis was\nperformed to identify the cell types contributing to BC aggressiveness. BC cell sequencing\ndata from The Cancer Genome Atlas (TCGA) database were then combined with univariate,\nleast absolute shrinkage and selection operator (LASSO), multivariate COX regression\nanalysis to identify biomarkers of BC prognosis to construct a BC. We identified\nbiomarkers of BC prognosis to construct a prognostic risk guidance system for BC.\nThe feedback of patients in different risk strata to immunotherapy was analyzed. Finally,\nthe regulation of prognostic genes on cancer cell activity was verified in vitro by Western\nblot and cell counting kit-8 (CCK8) assays.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Macrophages specifically expressing CD68 in BC were the cell type with the\nhighest AUCell score, and CD68 was the biomarker of Tumor-associated macrophages\n(TAMs). CD68 macrophages were potentially the critical cell type in the aggressive BC\nsubtype. Through univariate, LASSO, multivariate COX-based regression analysis.\nCTSS, GMFG, ANXA5, GSN, SLC2A3, and FTL were authenticated as prognostic biomarkers\n(p &lt; 0.05) and composed the Risk Score. Patients in the low-risk group showed\nan excellent survival advantage (p &lt; 0.01) and immunotherapy feedback. Additionally, inhibition\nof GSN expression decreased EMT activity to inhibit bladder cancer cell viability.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>In conclusion, this study provided feedback on the immune cell types associated\nwith aggressiveness in BC. Importantly, a prognostic management system for BC\nwas created based on the genes involved, providing more insight into the aggressive\npathological phenotype as well as the prognosis of BC.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867331666230824093312","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T11:52:02Z","timestamp":1692964322000},"page":"1523-1538","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Single-cell Sequencing Data Reveals Aggressive CD68-type\nMacrophages and Prognostic Models in Bladder Cancer"],"prefix":"10.2174","volume":"31","author":[{"given":"Chenyu","family":"Mao","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, The First Affiliated Hospital, College of Medicine, Zhejiang University,\nHangzhou, 310026, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nong","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, The First Affiliated Hospital, College of Medicine, Zhejiang University,\nHangzhou, 310026, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"Witjes J.A.","year":"2021","unstructured":"Witjes J.A.; Bruins H.M.; Cathomas R.; Comp&#xE9;rat E.M.; Cowan N.C.; Gakis G.; Hern&#xE1;ndez V.; Linares Espin&#xF3;s E.; Lorch A.; Neuzillet Y.; Rouanne M.; Thalmann G.N.; Veskim&#xE4;e E.; Ribal M.J.; van der Heijden A.G.; European association of urology guidelines on muscle-invasive and metastatic bladder cancer: Summary of the 2020 guidelines. Eur Urol  2021,79(1),82-104","journal-title":"Eur Urol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","volume":"70","author":"Patel V.G.","year":"2020","unstructured":"Patel V.G.; Oh W.K.; Galsky M.D.; Treatment of muscle- invasive and advanced bladder cancer in 2020. CA Cancer J Clin  2020,70(5),404-423","journal-title":"CA Cancer J Clin"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41585-018-0105-y","volume":"16","author":"Jordan B.","year":"2019","unstructured":"Jordan B.; Meeks J.J.; T1 bladder cancer: Current considerations for diagnosis and management. Nat Rev Urol  2019,16(1),23-34","journal-title":"Nat Rev Urol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.eururo.2009.06.028","volume":"56","author":"van Rhijn B.W.G.","year":"2009","unstructured":"van Rhijn B.W.G.; Burger M.; Lotan Y.; Solsona E.; Stief C.G.; Sylvester R.J.; Witjes J.A.; Zlotta A.R.; Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur Urol  2009,56(3),430-442","journal-title":"Eur Urol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.eururo.2016.06.025","volume":"71","author":"Yang Z.","year":"2017","unstructured":"Yang Z.; Li C.; Fan Z.; Liu H.; Zhang X.; Cai Z.; Xu L.; Luo J.; Huang Y.; He L.; Liu C.; Wu S.; Single-cell sequencing reveals variants in ARID1A, GPRC5A and MLL2 Driving Self-renewal of human bladder cancer stem cells. Eur Urol  2017,71(1),8-12","journal-title":"Eur Urol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.1038\/s41467-020-18916-5","volume":"11","author":"Chen Z.","year":"2020","unstructured":"Chen Z.; Zhou L.; Liu L.; Hou Y.; Xiong M.; Yang Y.; Hu J.; Chen K.; Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nat Commun  2020,11(1),5077","journal-title":"Nat Commun"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.cell.2020.05.017","volume":"181","author":"Oh D.Y.","year":"2020","unstructured":"Oh D.Y.; Kwek S.S.; Raju S.S.; Li T.; McCarthy E.; Chow E.; Aran D.; Ilano A.; Pai C.C.S.; Rancan C.; Allaire K.; Burra A.; Sun Y.; Spitzer M.H.; Mangul S.; Porten S.; Meng M.V.; Friedlander T.W.; Ye C.J.; Fong L.; Intratumoral CD4 T cells mediate anti-tumor cytotoxicity in human bladder cancer. Cell  2020,181(7),1612-1625.e13","journal-title":"Cell"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13073-020-00741-6","volume":"12","author":"Lee H.W.","year":"2020","unstructured":"Lee H.W.; Chung W.; Lee H.O.; Jeong D.E.; Jo A.; Lim J.E.; Hong J.H.; Nam D.H.; Jeong B.C.; Park S.H.; Joo K.M.; Park W.Y.; Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient. Genome Med  2020,12(1),47","journal-title":"Genome Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1038\/s41467-018-06152-x","volume":"9","author":"Chen C.","year":"2018","unstructured":"Chen C.; He W.; Huang J.; Wang B.; Li H.; Cai Q.; Su F.; Bi J.; Liu H.; Zhang B.; Jiang N.; Zhong G.; Zhao Y.; Dong W.; Lin T.; LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment. Nat Commun  2018,9(1),3826","journal-title":"Nat Commun"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.urology.2007.01.063","volume":"69","author":"Wang P.","year":"2007","unstructured":"Wang P.; Nishitani M.A.; Tanimoto S.; Kishimoto T.; Fukumori T.; Takahashi M.; Kanayama H.O.; Bladder cancer cell invasion is enhanced by cross-talk with fibroblasts through hepatocyte growth factor. Urology  2007,69(4),780-784","journal-title":"Urology"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/jcmm.14767","volume":"24","author":"Cao R.","year":"2020","unstructured":"Cao R.; Yuan L.; Ma B.; Wang G.; Qiu W.; Tian Y.; An EMT-related gene signature for the prognosis of human bladder cancer. J Cell Mol Med  2020,24(1),605-617","journal-title":"J Cell Mol Med"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1158\/1078-0432.CCR-06-2330","volume":"13","author":"Baumgart E.","year":"2007","unstructured":"Baumgart E.; Cohen M.S.; Neto B.S.; Jacobs M.A.; Wotkowicz C.; Rieger-Christ K.M.; Biolo A.; Zeheb R.; Loda M.; Libertino J.A.; Summerhayes I.C.; Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors. Clin Cancer Res  2007,13(6),1685-1694","journal-title":"Clin Cancer Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1002\/imt2.36","volume":"1","author":"Shen W.","year":"2022","unstructured":"Shen W.; Song Z.; Zhong X.; Huang M.; Shen D.; Gao P.; Qian X.; Wang M.; He X.; Wang T.; Li S.; Song X.; Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform. iMeta  2022,1(3),e36","journal-title":"iMeta"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"Stuart T.","year":"2019","unstructured":"Stuart T.; Butler A.; Hoffman P.; Hafemeister C.; Papalexi E.; Mauck W.M.; Hao Y.; Stoeckius M.; Smibert P.; Satija R.; Comprehensive integration of single-cell data. Cell  2019,177(7),1888-1902.e21","journal-title":"Cell"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"D870","DOI":"10.1093\/nar\/gkac947","volume":"51","author":"Hu C.","year":"2023","unstructured":"Hu C.; Li T.; Xu Y.; Zhang X.; Li F.; Bai J.; Chen J.; Jiang W.; Yang K.; Ou Q.; Li X.; Wang P.; Zhang Y.; CellMarker 2.0: An updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data. Nucleic Acids Res  2023,51(D1),D870-D876","journal-title":"Nucleic Acids Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1681\/ASN.2019040335","volume":"30","author":"Yu Z.","year":"2019","unstructured":"Yu Z.; Liao J.; Chen Y.; Zou C.; Zhang H.; Cheng J.; Liu D.; Li T.; Zhang Q.; Li J.; Yang X.; Ye Y.; Huang Z.; Long X.; Yang R.; Mo Z.; Single-cell transcriptomic map of the human and mouse bladders. J Am Soc Nephrol  2019,30(11),2159-2176","journal-title":"J Am Soc Nephrol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"Aibar S.","year":"2017","unstructured":"Aibar S.; Gonz&#xE1;lez-Blas C.B.; Moerman T.; Huynh-Thu V.A.; Imrichova H.; Hulselmans G.; Rambow F.; Marine J.C.; Geurts P.; Aerts J.; van den Oord J.; Atak Z.K.; Wouters J.; Aerts S.; SCENIC: Single-cell regulatory network inference and clustering. Nat Methods  2017,14(11),1083-1086","journal-title":"Nat Methods"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"Yoshihara K.","year":"2013","unstructured":"Yoshihara K.; Shahmoradgoli M.; Mart&#xED;nez E.; Vegesna R.; Kim H.; Torres-Garcia W.; Trevi&#xF1;o V.; Shen H.; Laird P.W.; Levine D.A.; Carter S.L.; Getz G.; Stemke-Hale K.; Mills G.B.; Verhaak R.G.W.; Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun  2013,4(1),2612","journal-title":"Nat Commun"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"Li T.","year":"2017","unstructured":"Li T.; Fan J.; Wang B.; Traugh N.; Chen Q.; Liu J.S.; Li B.; Liu X.S.; TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res  2017,77(21),e108-e110","journal-title":"Cancer Res"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"Langfelder P.","year":"2008","unstructured":"Langfelder P.; Horvath S.; WGCNA: An R package for weighted correlation network analysis. BMC Bioinf  2008,9(1),559","journal-title":"BMC Bioinf"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"Yu G.","year":"2012","unstructured":"Yu G.; Wang L.G.; Han Y.; He Q.Y.; clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS  2012,16(5),284-287","journal-title":"OMICS"},{"key":"ref=22","first-page":"28","volume":"128","author":"Therneau T.M.","year":"2015","unstructured":"Therneau T.M.; Lumley T.; Package \u2018survival\u2019. R Top Doc  2015,128,28-33","journal-title":"R Top Doc"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v039.i05","volume":"39","author":"Simon N.","year":"2011","unstructured":"Simon N.; Friedman J.; Hastie T.; Tibshirani R.; Regularization paths for cox\u2019s proportional hazards model via coordinate descent. J Stat Softw  2011,39(5),1-13","journal-title":"J Stat Softw"},{"key":"ref=24","first-page":"113","volume":"538","author":"Ripley B.","year":"2013","unstructured":"Ripley B.; Venables B.; Bates D.M.; Package \u2018mass\u2019. Cran R  2013,538,113-120","journal-title":"Cran R"},{"key":"ref=25","author":"Kassambara A.","year":"2017","unstructured":"Kassambara A.; Kosinski M.; Biecek P.; Package \u2018survminer\u2019. Drawing Survival Curves using \u2018ggplot  2017","journal-title":"Drawing Survival Curves using \u2018ggplot"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1186\/s12859-019-3059-z","volume":"20","author":"Tran A.N.","year":"2019","unstructured":"Tran A.N.; Dussaq A.M.; Kennell T.; Willey C.D.; Hjelmeland A.B.; HPAanalyze: An R package that facilitates the retrieval and analysis of the Human Protein Atlas data. BMC Bioinf  2019,20(1),463","journal-title":"BMC Bioinf"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"Mayakonda A.","year":"2018","unstructured":"Mayakonda A.; Lin D.C.; Assenov Y.; Plass C.; Koeffler H.P.; Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res  2018,28(11),1747-1756","journal-title":"Genome Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"Ritchie M.E.","year":"2015","unstructured":"Ritchie M.E.; Phipson B.; Wu D.; Hu Y.; Law C.W.; Shi W.; Smyth G.K.; limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res  2015,43(7),e47","journal-title":"Nucleic Acids Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"H&#xE4;nzelmann S.","year":"2013","unstructured":"H&#xE4;nzelmann S.; Castelo R.; Guinney J.; GSVA: Gene set variation analysis for microarray and RNA-Seq data. BMC Bioinf  2013,14(1),7","journal-title":"BMC Bioinf"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"Jiang P.","year":"2018","unstructured":"Jiang P.; Gu S.; Pan D.; Fu J.; Sahu A.; Hu X.; Li Z.; Traugh N.; Bu X.; Li B.; Liu J.; Freeman G.J.; Brown M.A.; Wucherpfennig K.W.; Liu X.S.; Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med  2018,24(10),1550-1558","journal-title":"Nat Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"e003416","DOI":"10.1136\/jitc-2021-003416","volume":"10","author":"Xu Y.","year":"2022","unstructured":"Xu Y.; Zeng H.; Jin K.; Liu Z.; Zhu Y.; Xu L.; Wang Z.; Chang Y.; Xu J.; Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer. J Immunother Cancer  2022,10(3),e003416","journal-title":"J Immunother Cancer"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.addr.2017.04.010","volume":"114","author":"Ngambenjawong C.","year":"2017","unstructured":"Ngambenjawong C.; Gustafson H.H.; Pun S.H.; Progress in tumor-associated macrophage (TAM)-targeted therapeutics. Adv Drug Deliv Rev  2017,114,206-221","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"105111","DOI":"10.1016\/j.phrs.2020.105111","volume":"161","author":"Zhang S.Y.","year":"2020","unstructured":"Zhang S.Y.; Song X.Y.; Li Y.; Ye L.L.; Zhou Q.; Yang W.B.; Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy. Pharmacol Res  2020,161,105111","journal-title":"Pharmacol Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"104723","DOI":"10.1016\/j.oraloncology.2020.104723","volume":"106","author":"Li B.","year":"2020","unstructured":"Li B.; Ren M.; Zhou X.; Han Q.; Cheng L.; Targeting tumor-associated macrophages in head and neck squamous cell carcinoma. Oral Oncol  2020,106,104723","journal-title":"Oral Oncol"},{"key":"ref=35","first-page":"151","volume":"56","author":"Lin F.","year":"2020","unstructured":"Lin F.; Yin H.B.; Li X.Y.; Zhu G.M.; He W.Y.; Gou X.; Bladder cancer cell-secreted exosomal miR-21 activates the PI3K\/AKT pathway in macrophages to promote cancer progression. Int J Oncol  2020,56(1),151-164","journal-title":"Int J Oncol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.3390\/ijms22136995","volume":"22","author":"Boutilier A.J.","year":"2021","unstructured":"Boutilier A.J.; Elsawa S.F.; Macrophage polarization states in the tumor microenvironment. Int J Mol Sci  2021,22(13),6995","journal-title":"Int J Mol Sci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/labinvest.2016.116","volume":"97","author":"Chistiakov D.A.","year":"2017","unstructured":"Chistiakov D.A.; Killingsworth M.C.; Myasoedova V.A.; Orekhov A.N.; Bobryshev Y.V.; CD68\/macrosialin: Not just a histochemical marker. Lab Invest  2017,97(1),4-13","journal-title":"Lab Invest"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/j.seminoncol.2017.10.013","volume":"44","author":"Alessandrini F.","year":"2017","unstructured":"Alessandrini F.; Pezz&#xE8; L.; Ciribilli Y.; LAMPs: Shedding light on cancer biology. Semin Oncol  2017,44(4),239-253","journal-title":"Semin Oncol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"679928","DOI":"10.3389\/fonc.2021.679928","volume":"11","author":"Jiang L.R.","year":"2021","unstructured":"Jiang L.R.; Zhang N.; Chen S.T.; He J.; Liu Y.H.; Han Y.Q.; Shi X.Q.; Yang J.J.; Mu D.Y.; Fu G.H.; Gao F.; PD-1-Positive tumor-associated macrophages define poor clinical outcomes in patients with muscle invasive bladder cancer through potential CD68\/PD-1 complex interactions. Front Oncol  2021,11,679928","journal-title":"Front Oncol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"e004133","DOI":"10.1136\/jitc-2021-004133","volume":"10","author":"Kremenovic M.","year":"2022","unstructured":"Kremenovic M.; Chan A.A.; Feng B.; B&#xE4;riswyl L.; Robatel S.; Gruber T.; Tang L.; Lee D.J.; Schenk M.; BCG hydrogel promotes CTSS-mediated antigen processing and presentation, thereby suppressing metastasis and prolonging survival in melanoma. J Immunother Cancer  2022,10(6),e004133","journal-title":"J Immunother Cancer"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1182\/bloodadvances.2018026070","volume":"3","author":"Aerbajinai W.","year":"2019","unstructured":"Aerbajinai W.; Ghosh M.C.; Liu J.; Kumkhaek C.; Zhu J.; Chin K.; Rouault T.A.; Rodgers G.P.; Glia maturation factor-&#x3B3; regulates murine macrophage iron metabolism and M2 polarization through mitochondrial ROS. Blood Adv  2019,3(8),1211-1225","journal-title":"Blood Adv"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"101634","DOI":"10.1016\/j.redox.2020.101634","volume":"36","author":"Xu F.","year":"2020","unstructured":"Xu F.; Guo M.; Huang W.; Feng L.; Zhu J.; Luo K.; Gao J.; Zheng B.; Kong L.D.; Pang T.; Wu X.; Xu Q.; Annexin A5 regulates hepatic macrophage polarization via directly targeting PKM2 and ameliorates NASH. Redox Biol  2020,36,101634","journal-title":"Redox Biol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1158\/2326-6066.CIR-16-0295","volume":"5","author":"Wang H.C.","year":"2017","unstructured":"Wang H.C.; Chen C.W.; Yang C.L.; Tsai I.M.; Hou Y.C.; Chen C.J.; Shan Y.S.; Tumor-associated macrophages promote epigenetic silencing of gelsolin through dna methyltransferase 1 in gastric cancer cells. Cancer Immunol Res  2017,5(10),885-897","journal-title":"Cancer Immunol Res"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s12935-020-01599-9","volume":"20","author":"Yao X.","year":"2020","unstructured":"Yao X.; He Z.; Qin C.; Deng X.; Bai L.; Li G.; Shi J.; SLC2A3 promotes macrophage infiltration by glycolysis reprogramming in gastric cancer. Cancer Cell Int  2020,20(1),503","journal-title":"Cancer Cell Int"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"5158","DOI":"10.1038\/s41388-019-0782-x","volume":"38","author":"Park J.E.","year":"2019","unstructured":"Park J.E.; Dutta B.; Tse S.W.; Gupta N.; Tan C.F.; Low J.K.; Yeoh K.W.; Kon O.L.; Tam J.P.; Sze S.K.; Hypoxia-induced tumor exosomes promote M2-like macrophage polarization of infiltrating myeloid cells and microRNA-mediated metabolic shift. Oncogene  2019,38(26),5158-5173","journal-title":"Oncogene"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s13287-019-1447-y","volume":"10","author":"Liu F.","year":"2019","unstructured":"Liu F.; Qiu H.; Xue M.; Zhang S.; Zhang X.; Xu J.; Chen J.; Yang Y.; Xie J.; MSC-secreted TGF-&#x3B2; regulates lipopolysaccharide-stimulated macrophage M2-like polarization via the Akt\/FoxO1 pathway. Stem Cell Res Ther  2019,10(1),345","journal-title":"Stem Cell Res Ther"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.canlet.2022.01.005","volume":"529","author":"Du S.","year":"2022","unstructured":"Du S.; Qian J.; Tan S.; Li W.; Liu P.; Zhao J.; Zeng Y.; Xu L.; Wang Z.; Cai J.; Tumor cell-derived exosomes deliver TIE2 protein to macrophages to promote angiogenesis in cervical cancer. Cancer Lett  2022,529,168-179","journal-title":"Cancer Lett"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"519","DOI":"10.5483\/BMBRep.2022.55.11.128","volume":"55","author":"Park D.","year":"2022","unstructured":"Park D.; Lim G.; Yoon S.J.; Yi H.S.; Choi D.W.; The role of immunomodulatory metabolites in shaping the inflammatory response of macrophages. BMB Rep  2022,55(11),519-527","journal-title":"BMB Rep"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"102463","DOI":"10.1016\/j.redox.2022.102463","volume":"56","author":"Hao X.","year":"2022","unstructured":"Hao X.; Zheng Z.; Liu H.; Zhang Y.; Kang J.; Kong X.; Rong D.; Sun G.; Sun G.; Liu L.; Yu H.; Tang W.; Wang X.; Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing. Redox Biol  2022,56,102463","journal-title":"Redox Biol"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867331666230824093312","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/220283\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867331666230824093312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T17:10:28Z","timestamp":1713373828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/220283\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867331666230824093312","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-05-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}